Concepedia

<i>RUNX3</i> methylation as a predictor for disease progression in patients with non‐muscle‐invasive bladder cancer

Chunri Yan, Youngwon Kim, Yun‐Sok Ha, Isaac Yi Kim, Yong‐June Kim, Seok Joong Yun, Sung‐Kwon Moon, Suk‐Chul Bae, Wun‐Jae Kim

Journal of Surgical Oncology · 2011 · 32 citations · 20 references

DOI

Abstract

RUNX3 methylation status predicted the risk of NMIBC progression independently of tumor stage. In conjunction with tumor grade, RUNX3 methylation status in patients with NMIBC strongly predicts disease progression.

References

20

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck et al. · European Urology · 2006 · 2.9K citations

, , +7

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

Maurizio Brausi, Laurence Collette, Karl‐Heinz Kurth et al. · European Urology · 2002 · 677 citations

, , +8

Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.

Riichiro Maruyama, Shinichi Toyooka, Kazuhito Toyo‐oka et al. · PubMed · 2001 · 423 citations

, , +13

Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.

Luc Girard, Sabine Zöchbauer‐Müller, A K Virmani et al. · PubMed · 2000 · 345 citations

, , +17

The American Joint Committee on Cancer: updating the strategies in cancer staging.

Frederick L. Greene · PubMed · 2002 · 227 citations

, , +7